Vor Biopharma Inc (VOR)
0.79
-0.01
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Total Liabilities (Quarterly): 43.04M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 43.04M |
| June 30, 2024 | 43.51M |
| March 31, 2024 | 44.00M |
| December 31, 2023 | 47.40M |
| September 30, 2023 | 48.24M |
| June 30, 2023 | 46.54M |
| March 31, 2023 | 47.32M |
| December 31, 2022 | 48.76M |
| September 30, 2022 | 47.64M |
| Date | Value |
|---|---|
| June 30, 2022 | 49.64M |
| March 31, 2022 | 39.82M |
| December 31, 2021 | 26.33M |
| September 30, 2021 | 25.68M |
| June 30, 2021 | 25.04M |
| March 31, 2021 | 25.75M |
| December 31, 2020 | 27.64M |
| September 30, 2020 | 25.33M |
| December 31, 2019 | 2.186M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.186M
Minimum
Dec 2019
49.64M
Maximum
Jun 2022
36.88M
Average
43.27M
Median
Total Liabilities (Quarterly) Benchmarks
| Organon & Co | 12.26B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.99M |
| Shareholders Equity (Quarterly) | 72.96M |